[HTML][HTML] Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

…, KT Rutkowski, F Ratangee, N Bilek… - … England Journal of …, 2018 - Mass Medical Soc
Background Recent Mycobacterium tuberculosis infection confers a predisposition to the
development of tuberculosis disease, the leading killer among global infectious diseases. H4:…

[HTML][HTML] T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

…, A Leslie, SM Behar, WA Hanekom, N Bilek… - Nature Medicine, 2023 - nature.com
Antigen-specific, MHC-restricted αβ T cells are necessary for protective immunity against
Mycobacterium tuberculosis, but the ability to broadly study these responses has been limited. …

[HTML][HTML] Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

…, C Hikuam, M Kaskar, M Musvosvi, N Bilek… - The Lancet Infectious …, 2021 - thelancet.com
Background Targeted preventive therapy for individuals at highest risk of incident tuberculosis
might impact the epidemic by interrupting transmission. We tested performance of a …

[HTML][HTML] RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

…, F Darboe, M Erasmus, WA Hanekom, N Bilek… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic signature…

Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo …

…, J Vergara, S Mabwe, N Bilek… - The Lancet …, 2018 - thelancet.com
Background A vaccine that prevents pulmonary tuberculosis in adults is needed to halt
transmission in endemic regions. This trial aimed to assess the safety and immunogenicity of …

Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection

E Nemes, V Rozot, H Geldenhuys, N Bilek… - American journal of …, 2017 - atsjournals.org
Rationale: Conversion from a negative to positive QuantiFERON-TB test is indicative of
Mycobacterium tuberculosis (Mtb) infection, which predisposes individuals to tuberculosis …

Multilocus Sequence Typing of Streptococcus pyogenes Representing Most Known emm Types and Distinctions among Subpopulation Genetic Structures

…, BG Spratt, A Kalia, A Bennett, N Bilek… - Journal of …, 2004 - Am Soc Microbiol
A long-term goal is to characterize the full range of genetic diversity within Streptococcus
pyogenes as it exists in the world today. Since the emm locus is subject to strong diversifying …

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

…, A Penn-Nicholson, Y Gregg, N Bilek… - The lancet Respiratory …, 2019 - thelancet.com
Background Infants are a key target population for new tuberculosis vaccines. We assessed
the safety and immunogenicity of the live-attenuated Mycobacterium tuberculosis vaccine …

Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind …

…, M Tameris, S Mabwe, N Bilek… - The Lancet …, 2021 - thelancet.com
Background A therapeutic vaccine that prevents recurrent tuberculosis would be a major
advance in the development of shorter treatment regimens. We aimed to assess the safety and …

[HTML][HTML] Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy …

…, K Hadley, C Hikuam, M Musvosvi, N Bilek… - The Lancet Global …, 2021 - thelancet.com
Background A rapid, blood-based triage test that allows targeted investigation for tuberculosis
at the point of care could shorten the time to tuberculosis treatment and reduce mortality. …